LONDON - Microscience Ltd. is forming a 50-50 joint venture company with the Hamburg, Germany, drug discovery services company Evotec OAI to develop small-molecule antimicrobial drugs based on targets generated by Microscience's functional genomics platform. (Bioworld International) Read More
